Gerresheimer (ETR:GXI) Stock Price Down 2.1% – Here’s Why

Gerresheimer AG (ETR:GXI)’s stock price was down 2.1% on Tuesday . The stock traded as low as €25.14 and last traded at €25.50. Approximately 83,951 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 140,925 shares. The stock had previously closed at €26.04.

Gerresheimer Stock Down 2.1%

The company has a current ratio of 0.98, a quick ratio of 0.40 and a debt-to-equity ratio of 164.82. The company has a market capitalization of $873.04 million, a price-to-earnings ratio of 7.64, a price-to-earnings-growth ratio of 0.82 and a beta of 0.45. The firm’s fifty day simple moving average is €23.38 and its two-hundred day simple moving average is €23.61.

About Gerresheimer

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.